These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10292027)

  • 21. Potential and actual drug product selection rates in Florida.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for pharmacists performing product selection.
    Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394
    [No Abstract]   [Full Text] [Related]  

  • 23. Prescription drug formularies: ensuring access to safe and effective medications.
    Weiss H
    Healthplan; 2002; 43(6):52-4. PubMed ID: 12506438
    [No Abstract]   [Full Text] [Related]  

  • 24. PBM industry today: who's managing drug costs?
    Martin SS
    Manag Care; 2001 Dec; 10(12):36-8. PubMed ID: 11795000
    [No Abstract]   [Full Text] [Related]  

  • 25. Rising costs concern physicians..
    Bryant BE; Boscarino J
    Am Med News; 1979 Nov; 22(45):suppl 1-2. PubMed ID: 10244807
    [No Abstract]   [Full Text] [Related]  

  • 26. The case for "dispense as written".
    Weston JK
    Va Med; 1979 Mar; 106(3):198-9. PubMed ID: 442785
    [No Abstract]   [Full Text] [Related]  

  • 27. How effectively do managed care organizations influence prescribing and dispensing decisions?
    Carroll NV
    Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. American Academy of Pediatrics Committee on Drugs: Generic prescribing, generic substitution, and therapeutic substitution.
    Pediatrics; 1987 May; 79(5):835. PubMed ID: 3575043
    [No Abstract]   [Full Text] [Related]  

  • 29. Inherent risk and market acceptance of generic drug products.
    Carroll NV; Wolfgang AP
    J Health Care Mark; 1989 Dec; 9(4):48-51. PubMed ID: 10296580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who's your biggest payer? Like it or not, it's managed care.
    Preston SH
    Med Econ; 2000 Dec; 77(23):130-4, 136, 138. PubMed ID: 11155563
    [No Abstract]   [Full Text] [Related]  

  • 32. Who's in charge here?
    Sayer Q
    Nurs Times; 1997 Nov 26-Dec 2; 93(48):62-4. PubMed ID: 9423487
    [No Abstract]   [Full Text] [Related]  

  • 33. [Your soul for a pen?].
    DeMaria AN
    G Ital Cardiol (Rome); 2007 May; 8(5):267-9. PubMed ID: 17650685
    [No Abstract]   [Full Text] [Related]  

  • 34. Formulary standards key to E-prescribing success.
    Schueth T
    Manag Care; 2004 Oct; 13(10):41-3. PubMed ID: 15535159
    [No Abstract]   [Full Text] [Related]  

  • 35. Strategies for developing a successful Medicare part D formulary.
    Stefanacci RG
    Manag Care; 2005 May; 14(5 Suppl):3-10. PubMed ID: 15962831
    [No Abstract]   [Full Text] [Related]  

  • 36. Patient power: getting the drug you need.
    Spragins EE
    Newsweek; 1999 Apr; 133(17):78. PubMed ID: 10351752
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of managed care on prescription drug use.
    Weiner JP; Lyles A; Steinwachs DM; Hall KC
    Health Aff (Millwood); 1991; 10(1):140-54. PubMed ID: 2045046
    [No Abstract]   [Full Text] [Related]  

  • 38. Physicians increasingly selective about health plan partners.
    Capitation Rates Data; 1998 Jul; 3(7):80-2. PubMed ID: 10345864
    [No Abstract]   [Full Text] [Related]  

  • 39. Physician satisfaction with formulary policies: is it access to formulary or nonformulary drugs that matters most?
    Glassman PA; Good CB; Kelley ME; Bradley M; Valentino M
    Am J Manag Care; 2004 Mar; 10(3):209-16. PubMed ID: 15032258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicians' willingness and barriers to considering cost when prescribing.
    Tseng CW; Buenconsejo-Lum L; Manlucu L; Hixon A
    Hawaii Med J; 2006 Nov; 65(11):318, 320-1. PubMed ID: 17265992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.